EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Severe combined immunodeficiency diagnosis and genetic defects

Carolina Sanchez Aranda, Mariana Pimentel Gouveia-Pereira, Celso Jose Mendanha da Silva, Maria Candida Faria Varanda Rizzo, Edson Ishizuka, Edgar Borges de Oliveira, Antonio Condino-Neto iD

Immunological Reviews · 2024-03 · 322 (1) · 138-147

DOI: 10.1111/imr.13310 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 29.01.2024. Verfasst von Carolina Sanchez Aranda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Federal University of São Paulo Medical School-UNIFESP, São Paulo, Brazi…. Hauptthemen laut MEDLINE: Severe Combined Immunodeficiency, Hematopoietic Stem Cell Transplantation, Agammaglobulinemia. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Jeffrey Modell Foundation, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe combined immunodeficiency (SCID) is a rare and life‐threatening genetic disorder that severely impairs the immune system's ability to defend the body against infections. Often referred to as the “bubble boy” disease, SCID gained widespread recognition due to the case of David Vetter, a young boy who lived in a sterile plastic bubble to protect him from germs. SCID is typically present at birth, and it results from genetic mutations that affect the development and function of immune cells, particularly T cells and B cells. These immune cells are essential for identifying and fighting off infections caused by viruses, bacteria, and fungi. In SCID patients, the immune system is virtually non‐existent, leaving them highly susceptible to recurrent, severe infections. There are several forms of SCID, with varying degrees of severity, but all share common features. Newborns with SCID often exhibit symptoms such as chronic diarrhea, thrush, skin rashes, and persistent infections that do not respond to standard treatments. Without prompt diagnosis and intervention, SCID can lead to life‐threatening complications and a high risk of mortality. There are over 20 possible affected genes. Treatment options for SCID primarily involve immune reconstitution, with the most well‐known approach being hematopoietic stem cell transplantation (HSCT). Alternatively, gene therapy is also available for some forms of SCID. Once treated successfully, SCID patients can lead relatively normal lives, but they may still require vigilant infection control measures and lifelong medical follow‐up to manage potential complications. In conclusion, severe combined immunodeficiency is a rare but life‐threatening genetic disorder that severely compromises the immune system's function, rendering affected individuals highly vulnerable to infections. Early diagnosis and appropriate treatment are fundamental. With this respect, newborn screening is progressively and dramatically improving the prognosis of SCID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Severe Combined ImmunodeficiencyHematopoietic Stem Cell TransplantationAgammaglobulinemiaMaleInfant, NewbornHumansT-LymphocytesEarly DiagnosisMutation

Stichwörter der Autor:innen

SCIDchilddiagnosisgeneticsimmunodeficiency

Autor:innen und Institutionen

  • Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Federal University of São Paulo Medical School-UNIFESP, São Paulo, Brazil.
  • Immunogenic Laboratories, São Paulo, Brazil.
  • Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Instituto Jo Clemente, and Immunogenic Laboratories, São Paulo, Brazil.

ORCID-Profile: Antonio Condino-Neto

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Jeffrey Modell Foundation
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Aranda, C. S., Gouveia-Pereira, M. P., da Silva, C. J. M., Rizzo, M. C. F. V., Ishizuka, E., de Oliveira, E. B., & Condino-Neto, A. (2024). Severe combined immunodeficiency diagnosis and genetic defects. Immunological Reviews, 322(1), 138-147. https://doi.org/10.1111/imr.13310

Vancouver

Aranda CS, Gouveia-Pereira MP, da Silva CJM, Rizzo MCFV, Ishizuka E, de Oliveira EB, et al. Severe combined immunodeficiency diagnosis and genetic defects. Immunological Reviews. 2024;322(1):138-147. doi:10.1111/imr.13310

BibTeX
@article{Aranda2024,
  author = {Aranda, Carolina Sanchez and Gouveia-Pereira, Mariana Pimentel and da Silva, Celso Jose Mendanha and Rizzo, Maria Candida Faria Varanda and Ishizuka, Edson and de Oliveira, Edgar Borges and Condino-Neto, Antonio},
  title = {Severe combined immunodeficiency diagnosis and genetic defects},
  journal = {Immunological Reviews},
  year = {2024},
  volume = {322},
  number = {1},
  pages = {138--147},
  doi = {10.1111/imr.13310}
}
Kostenlos starten →